Sunday, September 28, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Provide Mixed Ratings and Price Targets for Dutch Bros Inc NYSEBROS

Elaine Mendonca by Elaine Mendonca
January 16, 2024
in Breaking News
0
Finance_ Chart up
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As of January 16, 2024, analysts have set an average 12-month price target of $35.38 for Dutch Bros Inc. (NYSE:BROS), indicating a potential upside of 26.99% from the current price. Notable adjustments to ratings and price targets have been made by key analysts:

– Chris O’Cull from Stifel upgraded the rating to Buy, setting a new price target of $35.00, up from $32.00.
– Jeffrey Bernstein from Barclays also raised the rating to Equal-Weight, with a current price target of $31.00, up from $28.00.
– Nick Setyan from Wedbush upgraded the rating to Outperform, setting a new price target of $37.00, up from $35.00.
– John Ivankoe from JP Morgan upgraded the rating to Overweight, with a current price target of $35.00, up from $30.00.

However, there have also been some downgrades:

– Nick Setyan from Wedbush downgraded the rating to Outperform, with a current price target of $31.00, down from $37.00.
– Jeffrey Bernstein from Barclays also downgraded the rating to Equal-Weight, with a current price target of $26.00, down from $30.00.

Overall, the average 12-month price target has shown an upward trend, with the current average reflecting a 3.14% increase from the previous average price target of $31.86. Currently, the stock has been given a “Hold” rating by 8 analysts, with a 12-month stock price forecast of $33.25, representing an increase of 13.06% from the latest price.

BROS Stock Analysis: Price Rises 1.40% as Market Opens at $28.80 on January 16, 2024

On January 16, 2024, BROS stock opened at $28.80, which was $0.94 higher than its previous close. The stock managed to register a price increase of $0.39 since the market last closed, representing a rise of 1.40% in the stock’s value. Trading near the bottom of its 52-week range suggests relative weakness compared to its performance over the past year. Trading below its 200-day simple moving average indicates a downward trend. The opening price of $28.80 indicates positive market sentiment. Investors should closely monitor the price action of BROS in the coming days to determine its momentum. It is recommended to conduct further research and analysis before making any investment decisions.

BROS Stock Performance: Impressive Growth in Revenue, Net Income, and EPS in 2024

BROS Stock Performance: A Promising Start to 2024

On January 16, 2024, BROS showcased an impressive performance in terms of its stock performance. Let’s delve into the details of BROS’ stock performance on this significant day.

Comparing the total revenue of $739.01 million over the past year to the previous year, BROS has experienced a substantial increase of 48.43%. Additionally, the company’s total revenue also saw a notable increase of 5.85% since the last quarter, reaching $264.51 million.

Over the past year, the company’s net income stood at -$4.75 million. However, in the third quarter of the same year, BROS made a significant turnaround, reporting a net income of $4.21 million. This represents a remarkable increase of 63.19% since the previous year. Furthermore, BROS’ net income also experienced a substantial rise of 52.98% since the last quarter.

BROS has delivered impressive growth in earnings per share (EPS) as well. Over the past year, the company reported an EPS of -$0.09. However, in the third quarter of 2024, BROS achieved a notable increase in EPS, reaching $0.07. This represents a substantial growth of 64.62% since the previous year. Moreover, BROS’ EPS also witnessed a significant increase of 45.93% since the last quarter.

Overall, BROS has started the year 2024 on a highly positive note. The company’s stock performance on January 16, 2024, showcases significant growth in total revenue, net income, and earnings per share. With a 48.43% increase in total revenue since the previous year, BROS has demonstrated its ability to expand its market presence and generate higher levels of revenue. Additionally, the substantial increase in net income and EPS signifies BROS’ successful implementation of strategies to improve profitability and financial performance.

Investors and stakeholders can take confidence in BROS’ strong performance, which indicates the company’s potential for future growth and success. As BROS continues to execute its strategic initiatives and capitalize on market opportunities, it remains a stock to watch in the coming months.

Tags: BROS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Revolutionizing the Feminine Care Industry Compass Diversified and The Honey Pot Companys 380 Million Collaboration

Finance_ People trading stocks

Momentus Announces 4M Registered Direct Offering with Warrant Option

Healthcare Services Stock Exchange

Instil Bios ITIL306 Program Advancements and Future Possibilities in Cancer Treatment

Recommended

Super Micro Computer Stock

Super Micro’s Stock Plummets on Disappointing Earnings and Guidance

1 month ago
Healthcare-and-IT

Changing Sentiment Towards UnitedHealth Group Stock

2 years ago
DrugRetailers Trading online

Joann Stock Plummets Amid Bankruptcy Consideration and Financial Challenges

2 years ago
Healthcare Services Stock Exchange

Revolutionizing Cardiovascular Medicine Cardio Diagnostics Announces Nationwide Rollout of HeartRisk Platform

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Hensoldt’s Billion-Euro Expansion Plan Signals Defense Sector Transformation

Defense Sector Expansion Sparks Strategic Shift for Engine Manufacturer

DeFi Technologies Secures Landmark $100 Million Investment from Galaxy Digital

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

Ebix Navigates Post-Restructuring Landscape Amid Market Volatility

IGC Pharma: A High-Stakes Bet on Alzheimer’s Innovation

Trending

Stocks

BASF Shares Face Critical Test Amid Mounting Challenges

by Felix Baarz
September 28, 2025
0

BASF finds itself navigating one of the most challenging periods in its recent corporate history. The chemical...

Deutsche Telekom Stock

Deutsche Telekom Shares Face Conflicting Market Signals

September 28, 2025
Commerzbank Stock

Commerzbank Deploys €1 Billion Defense Against Takeover Bid

September 28, 2025
Hensoldt Stock

Hensoldt’s Billion-Euro Expansion Plan Signals Defense Sector Transformation

September 28, 2025
Deutz AG Stock

Defense Sector Expansion Sparks Strategic Shift for Engine Manufacturer

September 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BASF Shares Face Critical Test Amid Mounting Challenges
  • Deutsche Telekom Shares Face Conflicting Market Signals
  • Commerzbank Deploys €1 Billion Defense Against Takeover Bid

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com